News | April 30, 2015

Proton Partners International Announces Partnerships to Equip U.K.’s First Proton Beam Therapy Centers

IBA, Philips to supply proton therapy system and treatment planning software, respectively, to three locations

Proton Partners International, proton beam therapy centers, UK, IBA, Philips

April 30, 2015 — Proton Partners International Limited announced the appointment of global partners in its plans to build three proton beam therapy centers in the U.K. Partner organizations will provide state-of-the-art clinical equipment and technology solutions to the company.

Proton Partners International Ltd is to open treatment centers in Cardiff, London and Northumbria by 2017 and the first - Cardiff - will be operational next year. The establishment of the centers will mark a significant breakthrough in the provision of cancer treatment in the U.K. The lack of access to the latest radiotherapy treatment options in the U.K. has been highlighted in a flood of patient dramas in the press. Proton therapy hit the headlines when the delay in provision of machines in the National Health Service (NHS) led to many patients, acknowledged to need proton therapy, being transported to the U.S. and elsewhere for treatment, which unsurprisingly is much more costly than could be available in the U.K.

IBA (Ion Beam Applications) has been selected by Proton Partners to install its single-room proton therapy system, Proteus One, in each of the three U.K. centers.

Philips has been appointed to deliver software and technology tools including Philips' Pinnacle Treatment Planning, which delivers an intuitive planning environment that simplifies workflow. Philips will also provide big bore computed tomography (CT) scanners at each centre and a positron emission tomography (PET/CT) in the Cardiff center.

Before appointing its suppliers, Proton Partners International conducted an exhaustive selection process across two continents, including visiting the Willis Knighton Hospital in Shreveport, Louisiana, to see an IBA treatment room in operation. Final selection was made on technical and commercial merit.

Prof. Gordon McVie, senior consultant at the European Institute of Oncology and chairman of Proton Partners International, said: "These appointments are a significant milestone along the pathway to establishing the first proton beam therapy centers in the UK and reflect the quality and strength of our commitment to improve cancer treatment."

For more information: www.iba-worldwide.com

Related Content

ASTRO and ASCO Launch New Cancer Care Quality Registry
News | Radiation Therapy | January 22, 2018
January 22, 2018 — A registry that tracks the quality of medical care provided to patients receiving cancer treatment
First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
Overlay Init